U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C4H10O2
Molecular Weight 90.121
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of 1,4-Butanediol

SMILES

OCCCCO

InChI

InChIKey=WERYXYBDKMZEQL-UHFFFAOYSA-N
InChI=1S/C4H10O2/c5-3-1-2-4-6/h5-6H,1-4H2

HIDE SMILES / InChI

Molecular Formula C4H10O2
Molecular Weight 90.121
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Approval Year

PubMed

PubMed

TitleDatePubMed
Physical characterizations of microemulsion systems using tocopheryl polyethylene glycol 1000 succinate (TPGS) as a surfactant for the oral delivery of protein drugs.
2005-02-02
In vitro degradation of polyurethane orthodontic elastomeric modules.
2005-01
Preparation of macrocyclic 15N-labelled oligoaminodeoxysaccharides as probes for RNA-binding.
2004-12-07
Interaction between 1,4-butanediol and ethanol on operant responding and the cardiovascular system.
2004-12-03
The inkjet cleaner "Hurricane"--another GhB recipe.
2004-12
Butane-1,4-diyl bis(chloroacetate).
2004-12
Simultaneous analysis of gamma-hydroxybutyric acid and its precursors in urine using liquid chromatography-tandem mass spectrometry.
2004-11-12
4-methylpyrazole decreases 1,4-butanediol toxicity by blocking its in vivo biotransformation to gamma-hydroxybutyric acid.
2004-10
Enhanced production of acetoin and butanediol in recombinant Enterobacter aerogenes carrying Vitreoscilla hemoglobin gene.
2004-10
GHB (gamma-hydroxybutyrate) carrier-mediated transport across the blood-brain barrier.
2004-10
Optimization of binary porogen solvent composition for preparation of butyl methacrylate monoliths in capillary liquid chromatography.
2004-09-17
Biodegradation of aliphatic homopolyesters and aliphatic-aromatic copolyesters by anaerobic microorganisms.
2004-09-14
Adsorption of naphthalene on zeolite from aqueous solution.
2004-09-01
Monolithic columns with mixed modes of reversed-phase and anion-exchange stationary phase for capillary electrochromatography.
2004-07-30
Comparison of monolithic silica and polymethacrylate capillary columns for LC.
2004-07
Influence of reinforcer type and route of administration on gamma-hydroxybutyrate discrimination in rats.
2004-07
The Discriminative stimulus effects of gamma-hydroxybutyrate and related compounds in rats discriminating baclofen or diazepam: The role of GABA(B) and GABA(A) receptors.
2004-05
Design, synthesis and properties of a degradable polyurethane scaffold for meniscus regeneration.
2004-04
Comparison of the actions of gamma-butyrolactone and 1,4-butanediol in Swiss-Webster mice.
2004-04
Changes in macrophage function and morphology due to biomedical polyurethane surfaces undergoing biodegradation.
2004-04
Discriminative stimulus effects of gamma-hydroxybutyrate in pigeons: role of diazepam-sensitive and -insensitive GABA(A) and GABA(B) receptors.
2004-03
Metabolic analysis of acetate accumulation during xylose consumption by Paenibacillus polymyxa.
2004-03
Determination of gamma-hydroxybutyric acid in biological fluids by using capillary electrophoresis with indirect detection.
2004-02-05
Chronic 1,4-butanediol treatment in rats: cross-tolerance to gamma-hydroxybutyrate and (+/-)-baclofen.
2004-01-26
The crystal structures of Klebsiella pneumoniae acetolactate synthase with enzyme-bound cofactor and with an unusual intermediate.
2004-01-16
Synthesis and characterization of polyurethane and poly(ether urethane) nanocapsules using a new technique of interfacial polycondensation combined to spontaneous emulsification.
2004-01-09
Development of a solid-phase extraction method for simultaneous extraction of adipic acid, succinic acid and 1,4-butanediol formed during hydrolysis of poly(butylene adipate) and poly(butylene succinate).
2004-01-02
Production of L-2,3-butanediol by a new pathway constructed in Escherichia coli.
2004
The gamma-hydroxybutyrate withdrawal syndrome.
2004
Gamma-hydroxybutyrate: bridging the clinical-analytical gap.
2004
Gamma-butyrolactone and 1,4-butanediol: abused analogues of gamma-hydroxybutyrate.
2004
Synthesis of double-headed 2-5A-antisense chimeras and their ability to activate human RNase L.
2003-11-17
Crosslinked poly(methyl vinyl ether-co-maleic anhydride) as topical vehicles for hydrophilic and lipophilic drugs.
2003-11-13
Syntheses and physical characterization of new aliphatic triblock poly(L-lactide-b-butylene succinate-b-L-lactide)s bearing soft and hard biodegradable building blocks.
2003-11-11
New Zealand's first fatality linked to use of 1,4-butanediol (1,4-B, Fantasy): no evidence of coingestion or comorbidity.
2003-10-24
Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 30-2003. A 21-year-old man with sudden alteration of mental status.
2003-09-25
Aquatic toxicity of selected chemicals as a basic criterion for environmental classification.
2003-09
[Investigation of the cause of polyurethane catheter cracking during constant infusion of etoposide (VP-16) injection (2)--Analysis of ethanol eluting materials from catheter].
2003-09
Cellular interactions and degradation of aliphatic poly(ester amide)s derived from glycine and/or 4-amino butyric acid.
2003-09
Effects of temperature, inoculum size and starch hydrolyzate concentration on butanediol production by Bacillus licheniformis.
2003-09
Purification and characterization of novel salt-active acharan sulfate lyase from Bacteroides stercoris HJ-15.
2003-08
Drosophila metabolize 1,4-butanediol into gamma-hydroxybutyric acid in vivo.
2003-07-25
Vertically stratified flows in microchannels. Computational simulations and applications to solvent extraction and ion exchange.
2003-07-15
Poly(ether ester amide)s for tissue engineering.
2003-07
[Synthesis, characterization and blood compatibility studies of biomedical aliphatic polyurethanes].
2003-06
Lipase-catalyzed polycondensations: effect of substrates and solvent on chain formation, dispersity, and end-group structure.
2003-05-14
Intoxication due to 1,4-butanediol.
2003-05-05
Lipase-catalyzed enantioselective esterification of (S)-naproxen hydroxyalkyl ester in organic media.
2003-03
Synthesis of double-headed 2-5A-antisense chimeras and their ability to activate human RNase L.
2003
Surface characterization and platelet adhesion studies of aliphatic polyurethanes grafted by fluorocarbon oligomers: effect of fluorocarbon chain length and carboxylic acid group.
2002-01
Patents
Substance Class Chemical
Created
by admin
on Mon Mar 31 18:03:56 GMT 2025
Edited
by admin
on Mon Mar 31 18:03:56 GMT 2025
Record UNII
7XOO2LE6G3
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
NSC-406696
Preferred Name English
1,4-Butanediol
HSDB   INCI   MI  
INCI  
Official Name English
1,4-BUTANEDIOL [MI]
Common Name English
1,4-BUTANEDIOL [HSDB]
Common Name English
1,4-BUTYLENE GLYCOL
Systematic Name English
1,4-TETRAMETHYLENE GLYCOL
Common Name English
BUTANE-1,4-DIOL
Systematic Name English
TETRAMETHYLENE GLYCOL
Systematic Name English
1,4-DIHYDROXYBUTANE
Systematic Name English
Classification Tree Code System Code
WIKIPEDIA Designer-drugs-1,4-Butanediol
Created by admin on Mon Mar 31 18:03:56 GMT 2025 , Edited by admin on Mon Mar 31 18:03:56 GMT 2025
Code System Code Type Description
WIKIPEDIA
1,4-BUTANEDIOL
Created by admin on Mon Mar 31 18:03:56 GMT 2025 , Edited by admin on Mon Mar 31 18:03:56 GMT 2025
PRIMARY
FDA UNII
7XOO2LE6G3
Created by admin on Mon Mar 31 18:03:56 GMT 2025 , Edited by admin on Mon Mar 31 18:03:56 GMT 2025
PRIMARY
PUBCHEM
8064
Created by admin on Mon Mar 31 18:03:56 GMT 2025 , Edited by admin on Mon Mar 31 18:03:56 GMT 2025
PRIMARY
EPA CompTox
DTXSID2024666
Created by admin on Mon Mar 31 18:03:56 GMT 2025 , Edited by admin on Mon Mar 31 18:03:56 GMT 2025
PRIMARY
MERCK INDEX
m2788
Created by admin on Mon Mar 31 18:03:56 GMT 2025 , Edited by admin on Mon Mar 31 18:03:56 GMT 2025
PRIMARY Merck Index
CAS
110-63-4
Created by admin on Mon Mar 31 18:03:56 GMT 2025 , Edited by admin on Mon Mar 31 18:03:56 GMT 2025
PRIMARY
DAILYMED
7XOO2LE6G3
Created by admin on Mon Mar 31 18:03:56 GMT 2025 , Edited by admin on Mon Mar 31 18:03:56 GMT 2025
PRIMARY
SMS_ID
300000056706
Created by admin on Mon Mar 31 18:03:56 GMT 2025 , Edited by admin on Mon Mar 31 18:03:56 GMT 2025
PRIMARY
DRUG BANK
DB01955
Created by admin on Mon Mar 31 18:03:56 GMT 2025 , Edited by admin on Mon Mar 31 18:03:56 GMT 2025
PRIMARY
ECHA (EC/EINECS)
203-786-5
Created by admin on Mon Mar 31 18:03:56 GMT 2025 , Edited by admin on Mon Mar 31 18:03:56 GMT 2025
PRIMARY
HSDB
1112
Created by admin on Mon Mar 31 18:03:56 GMT 2025 , Edited by admin on Mon Mar 31 18:03:56 GMT 2025
PRIMARY
CHEBI
41189
Created by admin on Mon Mar 31 18:03:56 GMT 2025 , Edited by admin on Mon Mar 31 18:03:56 GMT 2025
PRIMARY
NSC
406696
Created by admin on Mon Mar 31 18:03:56 GMT 2025 , Edited by admin on Mon Mar 31 18:03:56 GMT 2025
PRIMARY
MESH
C039681
Created by admin on Mon Mar 31 18:03:56 GMT 2025 , Edited by admin on Mon Mar 31 18:03:56 GMT 2025
PRIMARY
Related Record Type Details
PARENT -> METABOLITE INACTIVE
Related Record Type Details
PARENT -> IMPURITY